Twenty-two participants with no sleep complaints underwent 3 conditions in a counterbalanced crossover study : ( 1 ) zolpidem-ER 12.5 mg ( bedtime dosing ) , ( 2 ) zaleplon 10 mg ( middle-of-the-night dosing ) , and ( 3 ) placebo .